Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Vangede Kiropraktik & Sundhed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   4.5% 3.9% 6.0% 8.5% 7.3% 7.8% 12.3% 12.3%   Credit score (0-100)   48 52 38 28 32 30 19 19   Credit rating   BBB BBB BBB BB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   636 921 992 916 1,103 1,255 0.0 0.0   EBITDA   205 571 31.0 -122 -49.3 -61.4 0.0 0.0   EBIT   142 480 -55.5 -200 -117 -114 0.0 0.0   Pre-tax profit (PTP)   128.2 465.9 -66.3 -219.3 -144.3 -140.9 0.0 0.0   Net earnings   100.0 362.4 -51.8 -165.5 -118.3 -110.2 0.0 0.0   Pre-tax profit without non-rec. items   128 466 -66.3 -219 -144 -141 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   127 86.1 49.6 20.9 2.8 0.0 0.0 0.0   Shareholders equity total   134 496 -1.3 -167 -285 -395 -445 -445   Interest-bearing liabilities   568 9.9 461 474 650 1,334 670 670   Balance sheet total (assets)   840 741 683 481 466 1,071 225 225   Net Debt   400 -143 267 417 574 1,275 670 670     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   636 921 992 916 1,103 1,255 0.0 0.0   Gross profit growth   331.7% 44.8% 7.7% -7.7% 20.4% 13.9% -100.0% 0.0%   Employees   1 1 2 1 3 4 0 0   Employee growth %   0.0% 0.0% 100.0% -50.0% 200.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   840 741 683 481 466 1,071 225 225   Balance sheet change%   209.4% -11.8% -7.7% -29.7% -3.2% 130.1% -79.0% 0.0%   Added value   205.3 570.9 31.0 -121.7 -38.7 -61.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   392 -182 -173 -157 -136 -106 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.3% 52.1% -5.6% -21.9% -10.6% -9.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.6% 60.7% -7.6% -30.1% -16.8% -10.3% 0.0% 0.0%   ROI %   30.4% 77.7% -11.0% -42.8% -20.9% -11.5% 0.0% 0.0%   ROE %   119.0% 115.0% -8.8% -28.4% -25.0% -14.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   16.0% 67.0% -0.2% -25.8% -38.0% -27.0% -66.4% -66.4%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   194.9% -25.1% 861.1% -342.5% -1,165.4% -2,075.8% 0.0% 0.0%   Gearing %   424.0% 2.0% -34,407.3% -284.1% -227.9% -337.5% -150.5% -150.5%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 4.8% 5.3% 4.0% 4.8% 2.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 1.0 0.4 0.2 0.3 1.1 0.0 0.0   Current Ratio   0.9 1.0 0.4 0.2 0.3 1.1 0.0 0.0   Cash and cash equivalent   168.1 153.2 193.9 57.3 75.5 59.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -25.5 0.2 -425.6 -512.8 -562.9 44.8 -335.2 -335.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   205 571 16 -122 -13 -15 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   205 571 16 -122 -16 -15 0 0   EBIT / employee   142 480 -28 -200 -39 -29 0 0   Net earnings / employee   100 362 -26 -166 -39 -28 0 0